RxDoctor Payments Data

Joseph Kelamis, MD

Plastic Surgery · Fort Smith, ARNPI 1821263765

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 64.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $200 and has fallen 73.3% since, to $53 in 2025. That places this record below the midpoint for plastic surgery clinicians in AR, where the typical reported total is $1,814.

$662in general payments, 2019–2025

Across 31 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$426
  • Mentor Worldwide LLC$106
  • Organogenesis Inc.$32
  • Polynovo North America LLC$24
  • Smith+Nephew$20
  • Integra Lifesciences Corporation$17
  • plus $38 from 3 others

What the payments were for

  • Food & beverage$662100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$662 in reported general payments places this provider in the 35th percentile of 23 plastic surgery providers in Arkansas.

See all plastic surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$9,531
Medicare patients
11
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron24$224
Oxycodone Hcl37$202

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →